There were 1,412 press releases posted in the last 24 hours and 438,492 in the last 365 days.

Global Tissue Diagnostics Market to 2024 by Product Type, Technology, Disease, End-User, Region

Dublin, July 23, 2019 (GLOBE NEWSWIRE) -- The "Tissue Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering.

The global tissue diagnostics market reached a value of US$ 3.8 Billion in 2018

Tissue diagnostics include the analysis and testing of specific tissue samples by capturing the biological context of diseases. They are used to detect certain medical conditions like cancer and inflammatory disorders and reveal the exact type and degree of malignancy which assists in identifying potential causes and treatment options.

Tissue diagnostics are highly accurate, inexpensive and can be carried out by different techniques like core and open biopsy. Nowadays, advanced technologies like immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology and special staining are also being employed for performing these diagnoses.

Owing to the declining fertility rates and increased life expectancy, the overall share of the geriatric population is currently experiencing steady growth worldwide. This is a crucial factor contributing to the market growth as older adults are more susceptible to chronic diseases and thus require frequent check-ups and diagnoses.

Apart from this, altering food patterns, rising alcohol consumption and reduced physical activities among individuals have led to a rise in the incidences of several lifestyle diseases. In addition to this, the rising prevalence of various types of cancers among all age groups has also led to a surge in demand for these diagnostic services.

The market to reach a value of US$ 5.5 Billion by 2024, registering a CAGR of 6.5% during 2019-2024.

Key Questions Answered in This Report:

  • How has the global tissue diagnostics market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global tissue diagnostics industry?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the disease?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the global tissue diagnostics industry?
  • What are the key driving factors and challenges in the global tissue diagnostics industry?
  • What is the structure of the global tissue diagnostics industry and who are the key players?
  • What is the degree of competition in the global tissue diagnostics industry?
  • What are the profit margins in the global tissue diagnostics industry?

Key Topics Covered:

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.4 Market Estimation
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Tissue Diagnostics Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Breakup by Product Type
5.4 Market Breakup by Technology
5.5 Market Breakup by Disease
5.6 Market Breakup by End-User
5.7 Market Breakup by Region
5.8 Market Forecast

6 Market Breakup by Product Type
6.1 Instruments
6.2 Consumables

7 Market Breakup by Technology
7.1 Immunohistochemistry
7.2 In Situ Hybridization
7.3 Digital Pathology and Workflow Management
7.4 Special Staining

8 Market Breakup by Disease
8.1 Breast Cancer
8.2 Gastric Cancer
8.3 Lymphoma
8.4 Prostate Cancer
8.5 Non-Small Cell Lung Cancer
8.6 Others

9 Market Breakup by End-User
9.1 Hospitals
9.2 Research Laboratories
9.3 Pharmaceutical Companies
9.4 Contract Research Organizations
9.5 Others

10 Market Breakup by Region

11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis
14.1 Price Indicators
14.2 Price Structure
14.3 Margin Analysis

15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Roche
15.3.2 Danaher
15.3.3 Thermo Fisher Scientific
15.3.4 Abbott
15.3.5 Agilent Technologies
15.3.6 Merck
15.3.7 Sakura Finetek Japan
15.3.8 Abcam
15.3.9 BD
15.3.10 Qiagen
15.3.11 Bio SB
15.3.12 Biogenex
15.3.13 Cell Signaling Technology

For more information about this report visit https://www.researchandmarkets.com/r/u0fr89

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Diagnostics

Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.